Neurological Support and Nerve Repair BPC-157 demonstrates neuroprotective properties across traumatic brain injury, stroke, spinal cord injury, and peripheral nerve damage models
These AIs are higher than the U.S
Retrieved from Agency for Healthcare Research and Quality: CPT | Changes 2022: An Insider's VIew
When to decrease dose Consider decreasing if: Persistent side effects that don't resolve Excellent results achieved and maintenance desired Budget constraints require conservation Stacking and wanting to optimize ratios Many researchers find they can reduce dose during maintenance phases after achieving initial goals during more intensive loading phases
Subscription options offer additional savings, making it more accessible for long-term use
Methylcobalamin is best, unless you suffer from Lebers hereditary optic neuropathy (1 in 30,000 to 50,000 people), where hydroxy B12 is safer